Skip to main content

Peer Review reports

From: Effective dose of remimazolam co-administered with remifentanil to facilitate I-gel insertion without neuromuscular blocking agents: an up-and-down sequential allocation trial

Original Submission
26 Dec 2022 Submitted Original manuscript
5 Jan 2023 Reviewed Reviewer Report
12 Jan 2023 Reviewed Reviewer Report - Yuji Suzuki
6 Feb 2023 Author responded Author comments - Han Bum Joe
Resubmission - Version 2
6 Feb 2023 Submitted Manuscript version 2
8 Mar 2023 Reviewed Reviewer Report - Yuji Suzuki
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
13 Mar 2023 Editorially accepted
16 Mar 2023 Article published 10.1186/s12871-023-02041-z

You can find further information about peer review here.

Back to article page